BayWa, Demag Cranes, Krones, Commerzbank: German Equity Preview

The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close.

DAX Index futures expiring in June slipped 0.3 percent to 7,182.5 at 8:36 a.m. in Frankfurt. The benchmark DAX Index rose 1.7 percent to 7,204.79 yesterday.

Adidas AG (ADS) : The world’s second-largest sporting- goods maker was raised to “overweight” from “neutral” at HSBC Holdings Plc. The shares climbed 1.2 percent to 50.51 euros.

BayWa AG (BYW) (BYW6 GY): The German farm products and building- materials company wants to raise sales at its renewable-energy unit to 1 billion euros ($1.4 billion) in the “mid-term” from 300 million euros currently, Handelsblatt reported, citing Chief Executive Officer Klaus Josef Lutz. The shares added 0.7 percent to 28.86 euros.

Commerzbank AG (CBK) : Germany’s second-largest bank plans to sell almost 75 percent of RWE AG (RWE)’s Amprion German power grid unit to investors such as insurance companies through a closed fund structure, Dow Jones said, citing unidentified people familiar with the matter. Commerzbank’s shares increased 1.6 percent to 3.10 euros, while RWE, the country’s second-largest utility, gained 1.8 percent to 38.86 euros.

EON AG (EOAN GY): Germany’s biggest utility was raised to “hold” from “sell” at Citigroup Inc. The shares rose 1.6 percent to 19.43 euros.

Fraport AG (FRA GY): The operator of Frankfurt airport was raised to “buy” from “hold” at Deutsche Bank AG. (DBK) The shares increased 0.5 percent to 54.14 euros.

Krones AG (KRN) : The world’s biggest maker of bottling and packaging equipment plans for management board member Christoph Klenk to replace Hans-Juergen Thaus as chief financial officer after he steps down for age reasons on Dec. 31. The stock rose 2.2 percent to 54 euros.

Demag Cranes AG (D9C) (D9C GY): Cevian Capital AB won’t sell its shares in the German crane maker to Terex Corp. unless the two companies agree, Financial Times Deutschland said, citing an interview with Cevian co-founder Lars Forberg. Demag’s management wants a higher purchase price than Terex offered and limitations on control rights, should the U.S. company acquire a majority, while Terex can’t accept those terms, FT Deutschland reported, without attribution. Demag slipped 0.2 percent to 44.58 euros.

Qiagen NV (QGEN) : The Dutch maker of disease-predicting tests said it started exclusive negotiations to buy 47 percent of Ipsogen SA before fully acquiring the specialist in blood cancer molecular diagnostics. Qiagen plans to expand its profiling and personalized health-care portfolios through the acquisition, the company said in an e-mailed statement today. The shares advanced 1.7 percent to 13.64 euros.

To contact the reporters on this story: Nicholas Comfort in Frankfurt at ncomfort1@bloomberg.net; Julie Cruz in Frankfurt at jcruz6@bloomberg.net

To contact the editor responsible for this story: Andrew Rummer at arummer@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.